ADAMTS6 and breast carcinoma: Several studies have demonstrated that it is dysregulated in some cancers such as breast cancer (BC) [18], prolactin (PRL) tumors [19], and colorectal cancer [20]; however, the precise role of ADAMTS6 in tumor development and the underlying mechanisms is unknown.